Press releases
- Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024
- Bio-Rad Names Anette Engelhardt Executive Vice President and President of Clinical Diagnostics Group
- Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
- Bio-Rad Reports First-Quarter 2024 Financial Results
- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
- Bio-Rad Announces Life Science Group Management Changes
More ▼
Key statistics
On Friday, Bio Rad Laboratories Inc (BIO.B:NYQ) closed at 294.23, 8.57% above its 52-week low of 271.00, set on Oct 27, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 300.39 |
---|---|
High | 300.39 |
Low | 294.23 |
Bid | -- |
Offer | -- |
Previous close | 294.23 |
Average volume | 218.00 |
---|---|
Shares outstanding | 28.52m |
Free float | 19.99m |
P/E (TTM) | -- |
Market cap | 8.91bn USD |
EPS (TTM) | -10.36 USD |
Data delayed at least 15 minutes, as of Jul 19 2024 21:10 BST.
More ▼